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Antibiotic resistance is an ever-increasing problem in global public health. Several multidrug-resistance bacteria have been reported to be a major cause of hospital and community-acquired infections.
Infections due to these resistant microbes have caused immense health care costs and have led to far worse clinical outcomes including death. Thus, there is an urgent need for a class of antimicrobials that can inhibit the menace of multidrug resistance.
Scientists at USF have designed novel bis-cyclic guanidine compounds that kill bacteria by compromising their cell membranes. Their mechanism of action is analogous to that of 
